Assembly Biosciences, Inc. Proceeds from Notes Payable
Assembly Biosciences, Inc. (ASMB) reported Proceeds from Notes Payable of $0 for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2014-05-14
- Assembly Biosciences, Inc. proceeds from notes payable for the quarter ending 2014-03-31 was $0.00.
- Assembly Biosciences, Inc. proceeds from notes payable for the quarter ending 2013-12-31 was $0.00.
- Assembly Biosciences, Inc. proceeds from notes payable for the quarter ending 2013-09-30 was $0.00.
- Assembly Biosciences, Inc. proceeds from notes payable for the quarter ending 2013-06-30 was $0.00.
- Assembly Biosciences, Inc. proceeds from notes payable for fiscal 2013 was $0.00.
- Assembly Biosciences, Inc. proceeds from notes payable for fiscal 2012 was $0.00.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month | Proceeds from Notes Payable 12 month as first filed | Proceeds from Notes Payable 81 month | Proceeds from Notes Payable 84 month | Proceeds from Notes Payable 90 month | Proceeds from Notes Payable 93 month | Proceeds from Notes Payable 96 month | Proceeds from Notes Payable 99 month | Proceeds from Notes Payable 102 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 2 quarters · filed 2014-05-14 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $11.52M 10-Q · filed 2014-05-14 | |||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $0.00 derived: sum of 2 quarters · filed 2014-03-31 | $0.00 derived: sum of 3 quarters · filed 2014-03-31 | $0.00 10-K · filed 2014-03-31 | $1.57M 10-K · filed 2014-03-31 | |||||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $0.00 10-Q · filed 2013-11-12 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $11.52M 10-Q · filed 2013-11-12 | |||||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $0.00 10-Q · filed 2013-08-09 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $11.52M 10-Q · filed 2013-08-09 | |||||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 2 quarters · filed 2014-05-14 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $11.52M 10-Q · filed 2013-05-10 | |||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $0.00 derived: sum of 2 quarters · filed 2014-03-31 | $0.00 derived: sum of 3 quarters · filed 2014-03-31 | $0.00 10-K · filed 2014-03-31 | $480.05K 10-K · filed 2013-03-18 | |||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $0.00 10-Q · filed 2013-11-12 | $11.52M 10-Q · filed 2012-11-13 | ||||||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $0.00 10-Q · filed 2013-08-09 | $11.52M 10-Q · filed 2012-08-09 | |||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-10 | |||||||||||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |